PlainRecalls

Diagnostic Hybrids, Inc.

Compiled from official public sources by the publisher.

8 recalls on record · Latest: May 16, 2018

Subscribe to new Diagnostic Hybrids, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Diagnostic Hybrids, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,730 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,730 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Devices (8)
  • CAT medical devices
  • CATS 1 category
  • LATEST May 16, 2018
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

Diagnostic Hybrids, Inc. accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Diagnostic Hybrids, Inc. compares to 14,151 recalling firms

Diagnostic Hybrids, Inc. ranks 1,730th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Diagnostic Hybrids, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1730th of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Diagnostic Hybrids, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Diagnostic Hybrids, Inc. holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate May 16, 2018

MicroVue BAP EIA, Model 8012, provides a quantitative measure of bone-specific alkaline phosphatase (BAP) activity in serum.
FDA Devices Low May 2, 2018

Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Intact Parathyroid Hormone (PTH) in serum.
FDA Devices Moderate May 2, 2018

MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating immune complexes in human serum or plasma. The assay uses highly pure, functional human C1q coated in the solid phase to capture immune complexes (CIC). In the first stage, CIC in the diluted patient samples and HAGG in the controls and standards are dispensed into the C1q coated assay wells. After incubation, unbound material is removed in a washing step and a ready to use conjugate (goat anti-human Ig-HR
FDA Devices Low May 2, 2018

MicroVue SC5b-9 Plus EIA (CE-IVD), Model A029. An enzyme immunoassay for the quantitation of SC5b-9 complex present in human plasma or serum.
FDA Devices Low May 2, 2018

MicroVue SC5b-9 Plus EIA (RUO), Model A020. Research use only (RUO) product. An enzyme immunoassay for the quantitation of SC5b-9 complex present in human plasma or serum.
FDA Devices Low May 2, 2018

MicroVue CIC-C1q EIA, Model A001. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. In certain disease states, immune complexes may initiate complement mediated damage of various organs and tissues. This activation of complement may begin a series of potentially destructive events including cell lysis, the production of anaphylatoxin
FDA Devices Moderate Sep 9, 2015

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
FDA Devices Low Feb 13, 2013

Diagnostic Hybrids, Inc., RhMK, Model #:49-0600, 49-0600A, 49-0102A, and 49-T075A. Culture media, used in the cultivation and amplification of viruses, such as respiratory viruses, enteroviruses, measles, and poliovirus from patient specimens.

Diagnostic Hybrids, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8 Ambriola Co., Inc., The 8

Similar medical devices volume

Nearest multi-notice firms in the same narrow category lane.

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8

Frequently Asked Questions

How many federal recall notices name Diagnostic Hybrids, Inc.? ▼
PlainRecalls indexes 8 distinct federal recall events naming Diagnostic Hybrids, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Diagnostic Hybrids, Inc. sit among other recalling firms? ▼
Diagnostic Hybrids, Inc. ranks #1,730 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Diagnostic Hybrids, Inc.'s notices? ▼
FDA Devices accounts for 8 of this firm's 8 indexed notices.
What product category dominates Diagnostic Hybrids, Inc.'s filing book? ▼
Filings for Diagnostic Hybrids, Inc. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Diagnostic Hybrids, Inc.: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Diagnostic Hybrids, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026